Japan Infectious Respiratory Disease Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Infectious Respiratory Disease Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI anything about the infectious respiratory disease diagnostics market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Japan infectious respiratory disease diagnostics market highlights
- The Japan infectious respiratory disease diagnostics market generated a revenue of USD 639.7 million in 2024 and is expected to reach USD 872.3 million by 2033.
- The Japan market is expected to grow at a CAGR of 3.6% from 2025 to 2033.
- In terms of segment, reagents was the largest revenue generating product in 2024.
- Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Infectious respiratory disease diagnostics market data book summary
| Market revenue in 2024 | USD 639.7 million |
| Market revenue in 2033 | USD 872.3 million |
| Growth rate | 3.6% (CAGR from 2025 to 2033) |
| Largest segment | Reagents |
| Fastest growing segment | Reagents |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents, Services |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
Other key industry trends
- In terms of revenue, Japan accounted for 5.2% of the global infectious respiratory disease diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China infectious respiratory disease diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,455.0 million by 2033.
The infectious respiratory disease diagnostics market in Japan is estimated to witness the significant growth during the forecast period owing to the presence of well-established public healthcare system, trained public health workers, and efficient healthcare services in educational centers in the country.
These factors have significantly contributed to the rapidly reducing mortality rates due to infectious diseases. Key factors driving the growth of the market in this country include high prevalence of infectious respiratory diseases, rise in awareness about nucleic acid testing, and increase in geriatric population that is susceptible to infectious diseases.
The country performed around 15 million tests, as of June 2021. Furthermore, as of March 2021, around 40,000 PCR tests are being conducted per day. This significant data is indicative of the market growth in Japan. Increasing approval of diagnostic products for COVID-19 by healthcare authority of Japan, to increase testing capacity in the country, is boosting market growth.
No credit card required*
Publish Date: Jan 16, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Respiratory Disease Diagnostics Market Scope
Infectious Respiratory Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
Japan Infectious Respiratory Disease Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Respiratory Disease Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 67.36% in 2024.
Horizon Databook has segmented the Japan infectious respiratory disease diagnostics market based on instruments, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
The infectious respiratory disease diagnostics market in Japan is estimated to witness the significant growth during the forecast period owing to the presence of well-established public healthcare system, trained public health workers, and efficient healthcare services in educational centers in the country.
These factors have significantly contributed to the rapidly reducing mortality rates due to infectious diseases. Key factors driving the growth of the market in this country include high prevalence of infectious respiratory diseases, rise in awareness about nucleic acid testing, and increase in geriatric population that is susceptible to infectious diseases.
The country performed around 15 million tests, as of June 2021. Furthermore, as of March 2021, around 40,000 PCR tests are being conducted per day. This significant data is indicative of the market growth in Japan. Increasing approval of diagnostic products for COVID-19 by healthcare authority of Japan, to increase testing capacity in the country, is boosting market growth.
- Japan Infectious Respiratory Disease Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Reagents
- Services
- Japan Infectious Respiratory Disease Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Molecular Diagnostics
- Immunoassays
- Microbiology
- Rapid/Point-of-Care Diagnostics
- Other Technologies
- Japan Infectious Respiratory Disease Diagnostics Market Application Outlook (Revenue, USD Million , 2021-2033)
- COVID-19
- Influenza
- Tuberculosis
- Respiratory Syncytial Virus (RSV)
- Non-tuberculosis Mycobacterium Testing
- Bacterial Pneumonia Testing
- Other Respiratory Diseases
- Japan Infectious Respiratory Disease Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes
Reasons to subscribe to Infectious Respiratory Disease Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Infectious Respiratory Disease Diagnostics Market Outlook databook
- Our clientele includes a mix of Infectious Respiratory Disease Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Infectious Respiratory Disease Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Infectious Respiratory Disease Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Infectious Respiratory Disease Diagnostics Market, 2021-2033 (US$M)
Japan Product - Infectious Respiratory Disease Diagnostics Market Statistics, 2024 - 2033 (US$M)
